Disclosed are fused cyclic compounds, method of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds of formula ##STR00001## Also disclosed are fused heterocyclic imido and amido compounds of formula ##STR00002## and stereoisomers thereof. The groups G, L, Z.sub.1, Z.sub.2, Q.sub.1, Q.sub.2, A.sub.1, A.sub.2, Y', and W' are defined herein.